Screening for peripheral arterial disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Andras, Alina ^a   Ferket, Bart ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; AMPUTATION; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CONTRAST ANGIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; HEALTH CARE PERSONNEL; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL HISTORY; MORBIDITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOTOELECTRIC PLETHYSMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULSE OXIMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TOE BRACHIAL INDEX; WALKING; AGED; ASYMPTOMATIC DISEASE; COMPLICATION; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

AGED; ASYMPTOMATIC DISEASES; HUMANS; INTERMITTENT CLAUDICATION; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 84901485301     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010835.pub2     Document Type: Review

References (55)

1. Behar T, Bosson JL, Galanaud JP, Thoret S, Rolland C, Bura-Rivière A, et al.Prevalence and risk factors of peripheral arterial disease in an outpatient screening campaign [Evaluation de la prévalence et des facteurs de risque de l'artériopathie oblitérante des membres inférieurs dans le cadre d'une campagne de dépistage ambulatoire]. Journal des Maladies Vasculaires 2013;38(1):22-8.
2. Bergiers S, Vaes B, Degryse J. To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study. BMC Family Practice 2011;12:39.
3. Delgado-Osorio H, Franqui-Rivera H, García-Palmieri MR, Díaz-Santana MV, Alvarez M. A peripheral artery disease screening study in Puerto Rico. Boletín de la Asociación Médica de Puerto Rico 2011;103(4):17-21.
4. Farkas K, Járai Z, Kolossváry E, Ludányi A, Clement DL, Kiss I, ERV Study Group. High prevalence of peripheral arterial disease in hypertensive patients: the evaluation of ankle-brachial index in Hungarian hypertensives screening program. Journal of Hypertension 2012;30(8):1526-32.
5. Kravos A, Bubnič-Sotošek K. Ankle-brachial Index screening for peripheral artery disease in asymptomatic patients between 50 and 70 years of age. Journal of International Medical Research 2009;37(5):1611-9.
6. Mourad JJ, Cacoub P, Collet JP, Becker F, Pinel JF, Huet D, et al.Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD. Journal of Vascular Surgery 2009;50(3):572-80.
7. Taylor-Piliae RE, Fair JM, Varady AN, Hlatky MA, Norton LC, Iribarren C, et al.Ankle brachial index screening in asymptomatic older adults. American Heart Journal 2011;161(5):979-85.
8. Grondal N, Henneberg EW, Lindholt JS. The Viborg vascular (VIVA) randomised screening trial: design, methods and preliminary findings. European Society for Vascular Surgery Annual Meeting; 2009; Oslo, Norway 2009.
9. Grondal N, Sogaard R, Henneberg EW, Lindholt JS. The Viborg vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: Study protocol. Trials 2010;11:67.
10. NCT00662480. Randomized preventive vascular screening trial of 65-74 year old men in the central region of Denmark. NCT00662480. http://clinicaltrials.gov/ct2/show/record/NCT00662480 (accessed 9 January 2014).
11. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al.Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012;126(24):2890-909.
12. Abramson BL, Huckell V, Anand S, Forbes T, Gupta A, Harris K, et al.Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary. Canadian Journal of Cardiology 2005;21:997-1006.
13. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al.2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology 2010;56(25):e50-e103.
14. Allen J, Overbeck K, Nath AF, Murray A, Stansby G. A prospective comparison of bilateral photoplethysmography versus the ankle-brachial pressure index for detecting and quantifying lower limb peripheral arterial disease. Journal of Vascular Surgery 2008;47(4):794-802.
15. The Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al.Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300(2):197-208.
16. Anonymous. Screening for peripheral arterial disease: recommendation statement. American Family Physician 2006;73:497-500.
17. Beckman JA, Jaff MR, Creager MA. The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?. Circulation 2006;114(8):861-6.
18. Bendermacher BL, Teijink JA, Willigendael EM, Bartelink ML, Peters RJ, de Bie RA, et al.A clinical prediction model for the presence of peripheral arterial disease--the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study. Vascular Medicine 2007;12:5-11.
19. Bhasin N, Scott DJA. Ankle brachial pressure index: identifying cardiovascular risk and improving diagnostic accuracy. Journal of the Royal Society of Medicine 2007;100(1):4-5.
20. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, et al.2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology 2013;29(2):151-67.
21. Collins R, Cranny G, Burch J, Aguiar-Ibáñez R, Craig D, Wright K, et al.A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technology Assessment 2007;11(20):iii-iv, xi-xiii, 1-184.
22. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985;71(3):516-22.
23. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysis data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Donnelly R, Hinwood D, London NJM. ABC of arterial and venous disease. Non-invasive methods of arterial and venous assessment. BMJ 2000;320(7236):698-701.
25. Ferket BS, Spronk S, Colkesen EB, Hunink MG. Systematic review of guidelines on peripheral artery disease screening. American Journal of Medicine 2013;125(2):198-208, e3.
26. Fowkes F, Murray G, Butcher I, Folsom A, Hirsch A, Couper D, et al.Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. European Journal of Preventive Cardiology 2014;21(3):310-20.
27. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al.2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Canadian Journal of Cardiology 2009;25:567-79.
28. Goyen M, Edelman M, Perreault P, O'Riordan E, Bertoni H, Taylor J, et al.MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005;236(3):825-33.
29. GRADE Working Group 2004. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4.
30. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
31. Heald CL, Fowkes FG, Murray GD, Price JF, Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006;189(1):61-9.
32. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
33. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al.Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317-24.
34. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al.ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-654.
35. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, van Ree JW. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. Journal of Clinical Epidemiology 2004;57(3):294-300.
36. Høyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. Journal of Vascular Surgery 2013;58(1):231-8.
37. Inglis SC, Hermis A, Shehab S, Newton PJ, Lal S, Davidson PM. Peripheral arterial disease and chronic heart failure: a dangerous mix. Heart Failure Reviews 2013;18(4):457-64.
38. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease?. JAMA 2006;295(5):536-46.
39. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. Journal of Clinical Epidemiology 1992;45(10):1101-9.
40. MacLeod-Roberts J. Vascular assessment. In: Merriman LM, Tollafield DR editor(s). Assessment of the lower limb. 1st Edition. Edinburgh: Churchill Livingstone, 1995:79-115.
41. McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, et al.Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. Journal of Vascular Surgery 2000;32(6):1164-71.
42. Mohler ER 3rd. Screening for peripheral artery disease. Circulation 2012;126:e111-2.
43. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143-421.
44. National Institute for Health and Clinical Excellence. Lower limb peripheral arterial disease (CG147). NICE clinical guidelines CG147 2012.
45. Oates CP, Allen J, Stansby G. Beyond the ankle-brachial pressure index for the diagnosis of peripheral arterial disease--time for a new look at photoplethysmography. Angiology 2012;64(7):492-3.
46. Parameswaran GI, Brand K, Dolan J. Pulse oximetry as a potential screening tool for lower extremity arterial disease in asymptomatic patients with diabetes mellitus. Archives of Internal Medicine 2005;165(4):442-6.
47. Ramos R, Baena-Díez JM, Quesada M, Solanas P, Subirana I, Sala J, et al.Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index. Atherosclerosis 2011;214:474-9.
48. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
49. Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vascular Health Risk Management 2007;3(2):229-34.
50. Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of peripheral arterial disease. A national clinical guideline. www.sign.ac.uk (accessed 23 July 2013).
51. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Review of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
52. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular and Endovascular Surgery 2007;33 Suppl 1:S1-S75.
53. Twine CP, Coulston J, Shandall A, McLain AD. Angioplasty versus stenting for superficial femoral artery lesions. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI:].
54. U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment. Annals of Internal Medicine 2009;151:474-82.
55. U.S. Preventive Services Task Force. The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction in asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Available from http://www.uspreventiveservicestaskforce.org/uspstf12/pad/pades100.pdf (accessed 16 January 2013).